Beneficial synergistic interactions of TNF-α and IL-6 in C2 skeletal myoblasts—Potential cross-talk with IGF system

References

• Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993; 54: 1–78
   PubMed Web of Science ®Google Scholar
• Alvarez B, Quinn LS, Busquets S, Lopez-Soriano FJ, Argiles JM. TNF-alpha modulates cytokine and cytokine receptors in C2C12 myotubes. Cancer Lett 2002a; 175: 181–185
   PubMedGoogle Scholar
• Alvarez B, Quinn LS, Busquets S, Quiles MT, Lopez-Soriano FJ, Argiles JM. Tumor necrosis factor-alpha exerts interleukin-6-dependent and -independent effects on cultured skeletal muscle cells. Biochim Biophys Acta 2002b; 1542: 66–72
   PubMedGoogle Scholar
• Argiles JM, Lopez-Soriano FJ. Catabolic proinflammatory cytokines. Curr Opin Clin Nutr Metab Care 1998; 1: 245–251
   PubMedGoogle Scholar
• Argiles JM, Busquets S, Felipe A, Lopez-Soriano FJ. Muscle wasting in cancer and ageing: Cachexia versus sarcopenia. Adv Gerontol 2006; 18: 39–54
   PubMedGoogle Scholar
• Bartoccioni E, Michaelis D, Hohlfeld R. Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. Immunol Lett 1994; 42: 135–138
   PubMedGoogle Scholar
• Barton BE. IL-6-like cytokines and cancer cachexia: Consequences of chronic inflammation. Immunol Res 2001; 23: 41–58
   PubMed Web of Science ®Google Scholar
• Barton BE, Murphy TF. Constitutive expression of IL-6-like cytokines in normal bone marrow: Implications for pathophysiology of myeloma. Cytokine 2000; 12: 1537–1545
   PubMedGoogle Scholar
• Brown AL, Graham DE, Nissley SP, Hill DJ, Strain AJ, Rechler MM. Developmental regulation of insulin-like growth factor II mRNA in different rat tissues. J Biol Chem 1986; 261: 13144–13150
   PubMedGoogle Scholar
• Cahlin C, Korner A, Axelsson H, Wang W, Lundholm K, Svanberg E. Experimental cancer cachexia: The role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia. Cancer Res 2000; 60: 5488–5493
   PubMed Web of Science ®Google Scholar
• Cantini M, Massimino ML, Rapizzi E, Rossini K, Catani C, Dalla Libera L, Carraro U. Human satellite cell proliferation in vitro is regulated by autocrine secretion of IL-6 stimulated by a soluble factor(s) released by activated monocytes. Biochem Biophys Res Commun 1995; 216: 49–53
   PubMedGoogle Scholar
• Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 1997; 272: 6653–6662
   PubMed Web of Science ®Google Scholar
• De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, Martini A, Ciliberto G, Fattori E. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997; 99: 643–650
   PubMed Web of Science ®Google Scholar
• De Rossi M, Bernasconi P, Baggi F, de Waal Malefyt R, Mantegazza R. Cytokines and chemokines are both expressed by human myoblasts: Possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol 2000; 12: 1329–1335
   PubMed Web of Science ®Google Scholar
• Fang CH, Sun X, Li BG, Fischer DR, Pritts TA, Penner G, Hasselgren PO. Burn injuries in rats upregulate the gene expression of the ubiquitin-conjugating enzyme E2(14k) in skeletal muscle. J Burn Care Rehabil 2000; 21: 528–534
   PubMedGoogle Scholar
• Febbraio MA. Signaling pathways for IL-6 within skeletal muscle. Exerc Immunol Rev 2003; 9: 34–39
   PubMedGoogle Scholar
• Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: Mechanisms for activation and possible biological roles. FASEB J 2002; 16: 1335–1347
   PubMed Web of Science ®Google Scholar
• Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett 1991; 285: 199–212
   PubMed Web of Science ®Google Scholar
• Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS. “Spontaneous” differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 1991; 266: 15917–15923
   PubMed Web of Science ®Google Scholar
• Foulstone EJ, Meadows KA, Holly JM, Stewart CE. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis. J Cell Physiol 2001; 189: 207–215
   PubMedGoogle Scholar
• Foulstone EJ, Huser C, Crown AL, Holly JM, Stewart CE. Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: Roles of IGF-I and TNFalpha. Exp Cell Res 2004; 294: 223–235
   PubMedGoogle Scholar
• Gallucci S, Provenzano C, Mazzarelli P, Scuderi F, Bartoccioni E. Myoblasts produce IL-6 in response to inflammatory stimuli. Int Immunol 1998; 10: 267–273
   PubMed Web of Science ®Google Scholar
• Godar S, Horejsi V, Weidle UH, Binder BR, Hansmann C, Stockinger H. M6P/IGFII–receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1. Eur J Immunol 1999; 29: 1004–1013
   PubMed Web of Science ®Google Scholar
• Grimble RF. Inflammatory response in the elderly. Curr Opin Clin Nutr Metab Care 2003; 6: 21–29
   PubMed Web of Science ®Google Scholar
• Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS, Jr. NF-kappaB-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia. Science 2000; 289: 2363–2366
   PubMed Web of Science ®Google Scholar
• Hasselgren PO, Menconi MJ, Fareed MU, Yang H, Wei W, Evenson A. Novel aspects on the regulation of muscle wasting in sepsis. Int J Biochem Cell Biol 2005; 37: 2156–2168
   PubMedGoogle Scholar
• Hill DJ, Crace CJ, Nissley SP, Morrell D, Holder AT, Milner RD. Fetal rat myoblasts release both rat somatomedin-C (SM-C)/insulin-like growth factor I (IGF I) and multiplication-stimulating activity in vitro: Partial characterization and biological activity of myoblast-derived SM-C/IGF I. Endocrinology 1985; 117: 2061–2072
   PubMedGoogle Scholar
• Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000; 19: 2548–2556
   PubMed Web of Science ®Google Scholar
• James PL, Stewart CE, Rotwein P. Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. J Cell Biol 1996; 133: 683–693
   PubMedGoogle Scholar
• Jourdan M, Zhang XG, Portier M, Boiron JM, Bataille R, Klein B. IFN-alpha induces autocrine production of IL-6 in myeloma cell lines. J Immunol 1991; 147: 4402–4407
   PubMed Web of Science ®Google Scholar
• Kallen KJ. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta 2002; 1592: 323–343
   PubMed Web of Science ®Google Scholar
• Langen RC, Schols AM, Kelders MC, van Der Velden JL, Wouters EF, Janssen-Heininger YM. Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways. Am J Physiol Cell Physiol 2002; 283: C714–C721
   PubMed Web of Science ®Google Scholar
• Langen RC, van Der Velden JL, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J 2004; 18: 227–237
   PubMed Web of Science ®Google Scholar
• Lawlor MA, Feng X, Everding DR, Sieger K, Stewart CE, Rotwein P. Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways. Mol Cell Biol 2000; 20: 3256–3265
   PubMed Web of Science ®Google Scholar
• Layne MD, Farmer SR. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts. Exp Cell Res 1999; 249: 177–187
   PubMedGoogle Scholar
• Li YP, Reid MB. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1165–R1170
   PubMed Web of Science ®Google Scholar
• Li YP, Schwartz RJ, Waddell ID, Holloway BR, Reid MB. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J 1998; 12: 871–880
   PubMed Web of Science ®Google Scholar
• Lloyd-Williams F, Mair FS, Leitner M. Exercise training and heart failure: A systematic review of current evidence. Br J Gen Pract 2002; 52: 47–55
   PubMed Web of Science ®Google Scholar
• Matthys P, Mitera T, Heremans H, van Damme J, Billiau A. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in d-galactosamine-sensitized and unsensitized mice. Infect Immun 1995; 63: 1158–1164
   PubMed Web of Science ®Google Scholar
• Meadows KA, Holly JM, Stewart CE. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. J Cell Physiol 2000; 183: 330–337
   PubMed Web of Science ®Google Scholar
• Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, Satoh S, Niwa M, Senoh H, Fujiwara H. T cell activation-associated hepatic injury: Mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994; 179: 1529–1537
   PubMed Web of Science ®Google Scholar
• Molotkov A, Satoh M, Tohyama C. Tumor growth and food intake in interleukin-6 gene knock-out mice. Cancer Lett 1998; 132: 187–192
   PubMedGoogle Scholar
• Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K, Taga T, Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 1993; 260: 1808–1810
   PubMed Web of Science ®Google Scholar
• Ogata A, Chauhan D, Urashima M, Teoh G, Treon SP, Anderson KC. Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells. Clin Cancer Res 1997; 3: 1017–1022
   PubMed Web of Science ®Google Scholar
• Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, Febbraio M, Saltin B. Searching for the exercise factor: Is IL-6 a candidate?. J Muscle Res Cell Motil 2003a; 24: 113–119
   PubMed Web of Science ®Google Scholar
• Pedersen BK, Steensberg A, Keller P, Keller C, Fischer C, Hiscock N, van Hall G, Plomgaard P, Febbraio MA. Muscle-derived interleukin-6: Lipolytic, anti-inflammatory and immune regulatory effects. Pflugers Arch 2003b; 446: 9–16
   PubMed Web of Science ®Google Scholar
• Radonic A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 2004; 313: 856–862
   PubMed Web of Science ®Google Scholar
• Rose-John S, Waetzig GH, Scheller J, Grotzinger J, Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 2007; 11: 613–624
   PubMed Web of Science ®Google Scholar
• Schmid C, Steiner T, Froesch ER. Preferential enhancement of myoblast differentiation by insulin-like growth factors (IGF I and IGF II) in primary cultures of chicken embryonic cells. FEBS Lett 1983; 161: 117–121
   PubMed Web of Science ®Google Scholar
• Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, Pedersen BK. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 2001; 537: 633–639
   PubMed Web of Science ®Google Scholar
• Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, Pedersen BK. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 2002a; 283: E1272–E1278
   PubMed Web of Science ®Google Scholar
• Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, Pedersen BK. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 2002b; 283: E1272–E1278
   PubMed Web of Science ®Google Scholar
• Stewart CE, Rotwein P. Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors. Physiol Rev 1996; 76: 1005–1026
   PubMed Web of Science ®Google Scholar
• Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med 2002; 347: 1941–1951
   PubMed Web of Science ®Google Scholar
• Suman OE, Spies RJ, Celis MM, Mlcak RP, Herndon DN. Effects of a 12-wk resistance exercise program on skeletal muscle strength in children with burn injuries. J Appl Physiol 2001; 91: 1168–1175
   PubMed Web of Science ®Google Scholar
• Thaloor D, Miller KJ, Gephart J, Mitchell PO, Pavlath GK. Systemic administration of the NF-kappaB inhibitor curcumin stimulates muscle regeneration after traumatic injury. Am J Physiol 1999; 277: C320–C329
   PubMed Web of Science ®Google Scholar
• Tuzun E, Li J, Wanasen N, Soong L, Christadoss P. Immunization of mice with T cell-dependent antigens promotes IL-6 and TNF-alpha production in muscle cells. Cytokine 2006; 35: 100–106
   PubMedGoogle Scholar
• Vermes C, Jacobs JJ, Zhang J, Firneisz G, Roebuck KA, Glant TT. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem 2002; 277: 16879–16887
   PubMed Web of Science ®Google Scholar
• Wang H, Casaburi R, Taylor WE, Aboellail H, Storer TW, Kopple JD. Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients. Kidney Int 2005a; 68: 352–361
   PubMed Web of Science ®Google Scholar
• Wang W, Slevin M, Kumar S, Kumar P. The cooperative transforming effects of PAX3-FKHR and IGF-II on mouse myoblasts. Int J Oncol 2005b; 27: 1087–1096
   PubMedGoogle Scholar
• Weyman CM, Wolfman A. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2. Endocrinology 1998; 139: 1794–1800
   PubMedGoogle Scholar
• Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977; 270: 725–727
   PubMed Web of Science ®Google Scholar